As the COVID-19 pandemic continues to evolve, GAP recommends that National Society Blood Services remain in constant contact with their own public health authorities to closely monitor their specific country situation and develop appropriate blood safety and sufficiency responses accordingly. In general, the major areas for blood service consideration in decision-making include epidemic and risk assessment surveillance, donor deferral and recall, inventory control / demand planning, communication, donor and staff shortages, and infection control.
The following links may provide information to assist with key decision-making regarding the management of donor, blood and staff safety, and developing a response to promote safe blood donation during this challenging time.
GAP also undertakes regular review of the WHO website to assess new COVID-19 technical documents as they are released. Anything relevant to public health and blood safety is addd to the WHO: COVID-19 Technical Guidance list, which can be accessed below.
Please note that given the rapidly evolving nature, the information which is available publicly may be revised regularly.
Each week, GAP updates the below list of WHO Technical Guidance documents on public health and blood safety. GAP reviews each new document and assesses the relevance and application for Red Cross / Red Crescent National Society blood programs before inclusion on the list.
Note. All information shared by GAP is provided “as is” without any warranty of fitness for any particular purpose. Reliance on the information is at the user’s sole risk and GAP expressly disclaims any liability of any nature arising out of the use of information. All copyright and intellectual property in the information remains vested in GAP or the member organisation that provided it, as applicable.
Last updated: 24/06/2021